Is mirtazapine (Remeron) considered a mood stabilizer, particularly for patients with a history of bipolar disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Mirtazapine a Mood Stabilizer?

No, mirtazapine is not a mood stabilizer—it is an antidepressant that can potentially trigger mania or hypomania in patients with bipolar disorder and should never be used as monotherapy in this population. 1

Classification and Mechanism

Mirtazapine is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA), not a mood stabilizer. 2, 3 It works by:

  • Antagonizing presynaptic alpha-2 adrenergic receptors to enhance noradrenergic neurotransmission 2
  • Blocking postsynaptic 5-HT2 and 5-HT3 receptors while enhancing 5-HT1 receptor-mediated serotonergic activity 2, 4
  • Having weak anticholinergic and histamine H1 antagonist properties 2

This mechanism is fundamentally different from true mood stabilizers like lithium, valproate, or lamotrigine, which work to prevent both manic and depressive episodes in bipolar disorder. 5

Critical Risk in Bipolar Disorder

Mirtazapine carries significant risk of inducing mania or hypomania in patients with bipolar disorder, occurring in approximately 0.2% of treated patients. 1 The FDA label explicitly warns:

  • Mania/hypomania occurred in approximately 0.2% (3/1,299 patients) of mirtazapine-treated patients 1
  • It should be used with caution in patients with a history of mania/hypomania 1
  • The American Academy of Child and Adolescent Psychiatry explicitly recommends against antidepressant monotherapy in bipolar disorder due to risk of mood destabilization, mania induction, and rapid cycling 5

What Actually Qualifies as a Mood Stabilizer

True mood stabilizers for bipolar disorder include:

  • Lithium - effective across all phases (acute mania, acute depression, maintenance) with superior long-term evidence 5, 6
  • Valproate - particularly effective for mixed or dysphoric mania 5
  • Lamotrigine - especially effective for preventing depressive episodes in maintenance therapy 5, 6
  • Atypical antipsychotics (aripiprazole, olanzapine, risperidone, quetiapine, ziprasidone) - first-line options for acute mania 5, 7, 6

These medications prevent both manic and depressive episodes and are FDA-approved for bipolar disorder treatment. 5

When Mirtazapine Might Be Used in Bipolar Disorder

If mirtazapine is considered for depressive symptoms in a patient with bipolar disorder:

  • It must ALWAYS be combined with a mood stabilizer (lithium, valproate, or lamotrigine) to prevent mood destabilization 5
  • The mood stabilizer should be established first before adding any antidepressant 5
  • Close monitoring for emergence of manic symptoms is essential 1
  • Consider olanzapine-fluoxetine combination as a first-line option for bipolar depression instead, as this has stronger evidence 5

Common Pitfall to Avoid

Never prescribe mirtazapine (or any antidepressant) as monotherapy in a patient with known or suspected bipolar disorder. 5 This is one of the most common medication errors in psychiatry and can trigger severe manic episodes or rapid cycling. 5 Always ensure adequate mood stabilization with lithium, valproate, or an atypical antipsychotic before considering antidepressant augmentation. 5

References

Guideline

First-Line Treatment of Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Mechanisms and Clinical Applications of Antipsychotics and Mood Stabilizers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Quetiapine for Mood Stabilization in Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the appropriate taper schedule for mirtazapine (Remeron) after one month of therapy in a female patient?
What adjustments should be made to the treatment plan for a patient experiencing depression, hyperactivity, sleep disturbances, and racing thoughts, who is currently taking mirtazapine (Remeron) 15mg, and has a history of worsening symptoms since the loss of a relative?
What is the next step in managing a patient who has been on mirtazapine (Remeron) 30mg for 1 week, after being on 15mg for 1 week, with a total treatment duration of 2.5 weeks?
Can mirtazapine be started as a first-line treatment for depression in a patient with a Body Mass Index (BMI) of 16.5?
Is mirtazapine (Remeron) suitable for a 3-week treatment of mild depression in an adult patient?
What are the recommended medications for a patient with Attention Deficit Hyperactivity Disorder (ADHD) with predominant inattentive symptoms?
What are the guidelines for taking lithium (a mood stabilizer) and furosemide (a loop diuretic) together in patients with bipolar disorder and hypertension or heart failure, considering potential risks of lithium toxicity and impaired renal function?
What is the recommended treatment for a patient presenting with dysuria, assuming a urinary tract infection?
What is the recommended stimulant therapy for a patient with chronic fatigue syndrome (CFS)?
What is the recommended treatment for a patient with a Ureaplasma infection?
What is the prognosis for an adult patient with mucoepidermoid carcinoma (MEC) of the parotid gland?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.